These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7429389)

  • 1. [Successful hormonal therapy of climacteric disorders].
    Täger F
    Fortschr Med; 1980 Jul; 98(26-27):1036-8. PubMed ID: 7429389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints.
    Lauritzen C
    Horm Metab Res; 1987 Nov; 19(11):579-84. PubMed ID: 3428874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of climacteric complaints with oestriol.
    Perović D; Kopajtic B; Stanković T
    Arzneimittelforschung; 1975 Jun; 25(6):962-4. PubMed ID: 1100057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental investigation of the effects of estriol on menopausal symptoms (author's transl)].
    Martius G; Horchler KH
    Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):938-43. PubMed ID: 1213259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal changes in aging from the viewpoint of the gynecologist].
    Wolf AS
    Fortschr Med; 1991 Jun; 109(18):374-8. PubMed ID: 1916554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of estriol replacement therapy for climacteric women.
    Yang TS; Tsan SH; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study.
    Kaari C; Haidar MA; Júnior JM; Nunes MG; Quadros LG; Kemp C; Stavale JN; Baracat EC
    Maturitas; 2006 Jan; 53(1):49-58. PubMed ID: 16257151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peroral treatment with natural human estrogens in the climacteric].
    Sele V; Obel E
    Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
    Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
    Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
    Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine in the treatment of menopausal symptoms.
    Ylikorkala O
    Ann Chir Gynaecol Fenn; 1975; 64(4):242-5. PubMed ID: 1103700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)].
    Wenderlein JM
    MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of climacteric urogenital disorders with an estriol-containing ointment].
    Koloszár S; Kovács L
    Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Climacteric symptoms: intensity, incidence and need for treatment. A study of 716 women between 40 and 70 years of age].
    Wenderlein JM; Clauder C
    Zentralbl Gynakol; 1996; 118(11):598-604. PubMed ID: 9082692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
    Høvik P; Sundsbak HP; Gaasemyr M; Sandvik L
    Maturitas; 1989 Mar; 11(1):75-82. PubMed ID: 2498620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of succinylestriol on the female climacteric].
    Ruiz Velasco V; Borjón Fernández L
    Ginecol Obstet Mex; 1974 Jan; 35(207):1-7. PubMed ID: 4827532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.